Standout Papers
Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
Why do patients with cancer die?
2024 Standout
Works of Pedro Oyuela being referenced
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
2012 Standout
A distinctive form of immune thrombocytopenia in a phase 2 study of alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Pedro Oyuela | 923 | 358 | 286 | 360 | 16 | 1.2k | |
| Cary Twyman | 811 | 294 | 238 | 322 | 17 | 994 | |
| M. Stojanovic | 806 | 268 | 250 | 358 | 18 | 1.0k | |
| Tamara Miller | 788 | 283 | 247 | 318 | 23 | 939 | |
| Amy Pace | 966 | 289 | 281 | 535 | 15 | 1.2k | |
| William H. Stuart | 968 | 520 | 208 | 335 | 18 | 1.3k | |
| Bella Ertik | 747 | 268 | 237 | 287 | 7 | 913 | |
| Paul O’Connor | 912 | 282 | 293 | 326 | 22 | 1.1k | |
| C. H. Polman | 782 | 249 | 264 | 371 | 12 | 896 | |
| Peter Alping | 751 | 311 | 116 | 337 | 13 | 913 | |
| A. Guseo | 678 | 272 | 178 | 315 | 24 | 980 |
All Works
Loading papers...